Ceapro

Ceapro CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Ceapro (CZO.V) as of Nov 1, 2026 is -15.29 %. In the previous year, Cash Return on Invested Capital (CROIC) was 18.03 % — a change of -184.80% (lower).

CROIC

-15.29 %

YoY

-184.80%

Last updated:

Cash Return on Invested Capital (CROIC) of Ceapro is 2023 -15.29 % . Cash Return on Invested Capital (CROIC) of Ceapro was 2022 18.03 % . It decreases by -184.80% lower compared to the previous year.

The Ceapro CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2016
-0.39 CAD
Jan 1, 2017
-9.63 CAD
Jan 1, 2018
-14.16 CAD
Jan 1, 2019
2.86 CAD
Jan 1, 2020
14.05 CAD
Jan 1, 2021
9.39 CAD
Jan 1, 2022
18.03 CAD
Jan 1, 2023
-15.29 CAD
The Ceapro CROIC history
YEARCROICYoY
-15.29 %-184.80%
18.03 %+92.13%
9.39 %-33.21%
14.05 %+391.66%
2.86 %-120.19%
-14.16 %+47.08%
-9.63 %+2,399.91%
-0.39 %-78.77%
-1.81 %-95.37%
-39.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ceapro Stock analysis

What does Ceapro do? Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ceapro stock

Cash Return on Invested Capital (CROIC) of Ceapro is -15.29 % in 2023.

Cash Return on Invested Capital (CROIC) of Ceapro changed from 18.03 % to -15.29 %, representing a -184.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Ceapro since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Ceapro with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ceapro

All Key Metrics — Ceapro